Author: GlobeNewswire

Bylvay(TM) (odevixibat) – Product Photo Bylvay(TM) is a once-daily drug indicated for the treatment of pruritus in PFIC Pamela Stephenson…

BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (Nasdaq: RDUS) announced today that it will release its second…

Following the June 2021 acquisition of the licensed facility, Lowell has commenced B2B operations serving regional cultivators with processing servicesSALINAS,…

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 20, 2021 (GLOBE…

SHANGHAI, China, July 20, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated…

MIRAMAR, Fla., July 19, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (NASDAQ:HCWB) (the “Company”), an innovative preclinical stage biopharmaceutical company…

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell” or the “Company”), a clinical-stage pharmaceutical…

— Shelf space for all three SKUs of VAZALORE is being reserved with ‘Coming Soon’ shelf placeholders — VAZALORE PLx…

PARIS and CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or…

LEXINGTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing…